skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 68  for All Library Resources

Results 1 2 3 4 next page
Refined by: Journal Title: Business Wire remove subject: Cancer remove subject: Care And Treatment remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera in Stage II Colorectal Cancer
Material Type:
Newspaper Article
Add to My Research

Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera in Stage II Colorectal Cancer

Business Wire, 2024-03-18

COPYRIGHT 2024 Business Wire, Inc.

Digital Resources/Online E-Resources

2
Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
Material Type:
Newspaper Article
Add to My Research

Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing

Business Wire, 2024-03-05

COPYRIGHT 2024 Business Wire, Inc.

Digital Resources/Online E-Resources

3
Medicare Extends Coverage of Natera's Signatera MRD Test to Ovarian Cancer and Neoadjuvant Breast Cancer
Material Type:
Newspaper Article
Add to My Research

Medicare Extends Coverage of Natera's Signatera MRD Test to Ovarian Cancer and Neoadjuvant Breast Cancer

Business Wire, 2024-02-26

COPYRIGHT 2024 Business Wire, Inc.

Digital Resources/Online E-Resources

4
Nature Medicine Publishes Two Studies Highlighting Signatera's Clinical Utility in Patients with Gastrointestinal Malignancies
Material Type:
Newspaper Article
Add to My Research

Nature Medicine Publishes Two Studies Highlighting Signatera's Clinical Utility in Patients with Gastrointestinal Malignancies

Business Wire, 2024-01-25

COPYRIGHT 2024 Business Wire, Inc.

Digital Resources/Online E-Resources

5
The Worldwide Market for Liquid Biopsy, 6th Edition - ResearchAndMarkets.com
Material Type:
Newspaper Article
Add to My Research

The Worldwide Market for Liquid Biopsy, 6th Edition - ResearchAndMarkets.com

Business Wire, 2024-01-22

COPYRIGHT 2024 Business Wire, Inc.

Digital Resources/Online E-Resources

6
City of Hope Doctors and Scientists Present Innovative Research at Largest Gathering on Breast Cancer Research
Material Type:
Newspaper Article
Add to My Research

City of Hope Doctors and Scientists Present Innovative Research at Largest Gathering on Breast Cancer Research

Business Wire, 2023-12-08

COPYRIGHT 2023 Business Wire, Inc.

Digital Resources/Online E-Resources

7
Vizient Explores Cardiac Ablation Modalities, Advancements in Remote Patient Monitoring and Imaging Alternatives for Early Breast Cancer Detection
Material Type:
Newspaper Article
Add to My Research

Vizient Explores Cardiac Ablation Modalities, Advancements in Remote Patient Monitoring and Imaging Alternatives for Early Breast Cancer Detection

Business Wire, 2023-12-06

COPYRIGHT 2023 Business Wire, Inc.

Digital Resources/Online E-Resources

8
Natera Announces Randomized, Phase III TREAT ctDNA Trial in Early-Stage Breast Cancer
Material Type:
Newspaper Article
Add to My Research

Natera Announces Randomized, Phase III TREAT ctDNA Trial in Early-Stage Breast Cancer

Business Wire, 2023-11-08

COPYRIGHT 2023 Business Wire, Inc.

Digital Resources/Online E-Resources

9
Natera Announces Completion of Enrollment to the Randomized, Phase III ALTAIR Trial of Signatera in Colorectal Cancer
Material Type:
Newspaper Article
Add to My Research

Natera Announces Completion of Enrollment to the Randomized, Phase III ALTAIR Trial of Signatera in Colorectal Cancer

Business Wire, 2023-07-28

COPYRIGHT 2023 Business Wire, Inc.

Digital Resources/Online E-Resources

10
Natera Announces New Publication from I-SPY2 Trial Reinforcing Clinical Utility of Signatera for Breast Cancer Patients in the Neoadjuvant Setting
Material Type:
Newspaper Article
Add to My Research

Natera Announces New Publication from I-SPY2 Trial Reinforcing Clinical Utility of Signatera for Breast Cancer Patients in the Neoadjuvant Setting

Business Wire, 2023-05-08

COPYRIGHT 2023 Business Wire, Inc.

Digital Resources/Online E-Resources

11
New Publication Demonstrates Utility of Natera's Signatera Test in Melanoma
Material Type:
Newspaper Article
Add to My Research

New Publication Demonstrates Utility of Natera's Signatera Test in Melanoma

Business Wire, 2023-03-22

COPYRIGHT 2023 Business Wire, Inc.

Digital Resources/Online E-Resources

12
American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Now Includes Breast Cancer Index to Guide Decisions about Extended Endocrine Therapy
Material Type:
Newspaper Article
Add to My Research

American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Now Includes Breast Cancer Index to Guide Decisions about Extended Endocrine Therapy

Business Wire, 2022-04-25

COPYRIGHT 2022 Business Wire, Inc.

Digital Resources/Online E-Resources

13
City of Hope and Osel Announce Live Biotherapeutic Product CBM588 May Enhance Efficacy of Immunotherapy for Patients With Metastatic Kidney Cancer
Material Type:
Newspaper Article
Add to My Research

City of Hope and Osel Announce Live Biotherapeutic Product CBM588 May Enhance Efficacy of Immunotherapy for Patients With Metastatic Kidney Cancer

Business Wire, 2022-02-28

COPYRIGHT 2022 Business Wire, Inc.

Digital Resources/Online E-Resources

14
Hologic Debuts Documentary-Style Film Highlighting One Woman's Breast Cancer Journey Timed to Breast Reconstruction Awareness Day
Material Type:
Newspaper Article
Add to My Research

Hologic Debuts Documentary-Style Film Highlighting One Woman's Breast Cancer Journey Timed to Breast Reconstruction Awareness Day

Business Wire, 2021-10-20

COPYRIGHT 2021 Business Wire, Inc.

Digital Resources/Online E-Resources

15
City of Hope and Osel Announce Exclusive License for Intellectual Property on the Use of Live Biotherapeutic Product CBM588 for Oncology Therapeutic Applications
Material Type:
Newspaper Article
Add to My Research

City of Hope and Osel Announce Exclusive License for Intellectual Property on the Use of Live Biotherapeutic Product CBM588 for Oncology Therapeutic Applications

Business Wire, 2021-07-14

COPYRIGHT 2021 Business Wire, Inc.

Digital Resources/Online E-Resources

16
Study: Testosterone Pellet Therapy Reduces Breast Cancer Incidence in Women
Material Type:
Newspaper Article
Add to My Research

Study: Testosterone Pellet Therapy Reduces Breast Cancer Incidence in Women

Business Wire, 2021-05-11

COPYRIGHT 2021 Business Wire, Inc.

Digital Resources/Online E-Resources

17
City of Hope and San Antonio Regional Hospital to Expand Access to Cancer Care in the Inland Empire
Material Type:
Newspaper Article
Add to My Research

City of Hope and San Antonio Regional Hospital to Expand Access to Cancer Care in the Inland Empire

Business Wire, 2017-02-01

COPYRIGHT 2017 Business Wire, Inc.

Digital Resources/Online E-Resources

18
Biocon Collaborates with Advaxis for 'ADXS-HPV' A Novel Cancer Immunotherapy
Material Type:
Newspaper Article
Add to My Research

Biocon Collaborates with Advaxis for 'ADXS-HPV' A Novel Cancer Immunotherapy

Business Wire, 2014-01-22

COPYRIGHT 2014 Business Wire, Inc.

Digital Resources/Online E-Resources

19
BioTime's Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTM
Material Type:
Newspaper Article
Add to My Research

BioTime's Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTM

Business Wire, 2013-01-31

COPYRIGHT 2013 Business Wire, Inc.

Digital Resources/Online E-Resources

20
GE Healthcare to Showcase Innovative Breast Cancer Solutions from Screening through Monitoring at SABCS 2012
Material Type:
Newspaper Article
Add to My Research

GE Healthcare to Showcase Innovative Breast Cancer Solutions from Screening through Monitoring at SABCS 2012

Business Wire, 2012-12-05

COPYRIGHT 2012 Business Wire, Inc.

Digital Resources/Online E-Resources

Results 1 - 20 of 68  for All Library Resources

Results 1 2 3 4 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2007  (6)
  2. 2007 To 2010  (24)
  3. 2011 To 2013  (21)
  4. 2014 To 2022  (7)
  5. After 2022  (11)
  6. More options open sub menu

Searching Remote Databases, Please Wait